There were more developments on the health front Monday, amid dire news involving the coronavirus pandemic.
In New York, the health-care sector picked up 1.2%, while in Canada, the hike was 1.3%, although there were no Canadian small-cap stocks with new tidings.
Boca Raton, Fla-based Connectyx Technologies Holdings Group, Inc. (OTC: CTYX) announced it is in licensing discussions for a novel monoclonal antibody (mAB) to treat brain cancer. The Company plans to grow its product pipeline through an active program of acquisition, in-licensing and sub-licensing of new technologies.
The company, a development-stage biomedical company focusing on novel treatments for rare diseases today announced it is in licensing discussions for a novel monoclonal antibody (mAB) to treat brain cancer. CTYX plans to grow its product pipeline through an active program of acquisition, in-licensing and sub-licensing of new technologies.
CTYX shares galloped 25% by noon hour Monday to 0.875 cents, on 6.3 million shares.
